Search
Brainstorm Cell Therapeutics Inc
BCLIAdd to Watchlist
1.170USD
0.0000.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
9.26MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
1
analysts
Hold
Current Rating
17.000
Target Price
+1352.99%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
Total
Median
Average
Company name
Ratings
Analysts
No Data
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
How have Brainstorm Cell Therapeutics IncBCLI's recent earnings per share performed?
The market expectation was USD -0.19, while Brainstorm Cell Therapeutics IncBCLI's earnings per share (EPS) for the previous quarter was USD -0.34. EPS for the next quarter is expected at USD -0.35.
What is the analyst rating for Brainstorm Cell Therapeutics Inc?
Based on the ratings of Brainstorm Cell Therapeutics Inc's stock from 1 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.